# Biomapas: We Keep Promises\. Always\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Biomapas](https://www.biomapas.com/)
- [EAEU \& CIS Medicinal Product Registration](https://www.biomapas.com/eaeu-cis-medicinal-product-registration/)
- [Homepage block test](https://www.biomapas.com/homepage-block-test/)
- [Shaping the Future of Biomapas: Interview with Xavier Duburcq, CEO \& Alexander Winterling, Chairman of the Board](https://www.biomapas.com/shaping-the-future-of-biomapas-interview-with-xavier-duburcq-ceo-alexander-winterling-chairman-of-the-board/)
- [Home](https://www.biomapas.com/home-video/)

## Posts
- [Centralized Pharmacovigilance: Ensuring Compliance and Efficiency Across Global Markets](https://www.biomapas.com/centralized-pharmacovigilance-global-compliance/): This article explores the benefits of centralized pharmacovigilance outsourcing and the single\-provider model\.
- [Setting Up A Pharmacovigilance System](https://www.biomapas.com/setting-up-a-pharmacovigilance-system/)
- [How To Manage An Early Phase Oncology Study: Project Manager Insights](https://www.biomapas.com/how-to-manage-an-early-phase-oncology-trial/)
- [When Do Biotech Companies and Startups Need Pharmacovigilance](https://www.biomapas.com/when-do-biotech-companies-and-startups-need-pharmacovigilance/): Many biotech startups assume pharmacovigilance begins after approval, but regulatory expectations and clinical trial complexity often require safety oversight much earlier\. Learn when pharmacovigilance becomes essential and how to stay compliant as you scale\.
- [How to Build Clinical Safety for Biotechs Without a Full Department](https://www.biomapas.com/how-to-build-clinical-safety-for-biotechs-without-a-full-department/): Discover how biotech companies can build scalable clinical safety management early, ensuring compliance, oversight, and efficient operations across development phases\.

## Quizzes \& Surveys
- [Testing](https://www.biomapas.com/qsm_quiz/testing/)

## Draw Attention
- [Medical Information](https://www.biomapas.com/?da_image=medical-information)
- [Pharmacovigilance](https://www.biomapas.com/?da_image=pharmacovigilance)
- [Clinical Research](https://www.biomapas.com/?da_image=clinical-research)
- [Regulatory Affairs](https://www.biomapas.com/?da_image=11021)

## Tags
- [Blog](https://www.biomapas.com/tag/blog/)
- [Webinar](https://www.biomapas.com/tag/webinar/)
- [Case Study](https://www.biomapas.com/tag/case-study/)
- [Biomapas Insights](https://www.biomapas.com/tag/biomapas-insights/)
- [Whitepaper](https://www.biomapas.com/tag/whitepaper/)

## Type
- [row](https://www.biomapas.com/layout_type/row/)
- [module](https://www.biomapas.com/layout_type/module/)
- [section](https://www.biomapas.com/layout_type/section/)
- [layout](https://www.biomapas.com/layout_type/layout/)

## Module Width
- [regular](https://www.biomapas.com/module_width/regular/)

## Scope
- [not\_global](https://www.biomapas.com/scope/not_global/)
- [global](https://www.biomapas.com/scope/global/)

## Type
- [template](https://www.biomapas.com/et_tb_item_type/template/)

## Page Categories
- [Clinical](https://www.biomapas.com/page_category/clinical/)
- [Pharmacovigilance](https://www.biomapas.com/page_category/pharmacovigilance/)
- [Regulatory](https://www.biomapas.com/page_category/regulatory/)
- [Medical Information](https://www.biomapas.com/page_category/medical-information/)

## Phases
- [Post Marketing](https://www.biomapas.com/phaes/post-marketing/)
- [Development](https://www.biomapas.com/phaes/development/)
- [Marketing Authorization](https://www.biomapas.com/phaes/marketing-authorization/)

## Timelines
- [History](https://www.biomapas.com/timeline/biomapas-history/)
- [Events](https://www.biomapas.com/timeline/biomapas-events/)
- [PV EAEU](https://www.biomapas.com/timeline/pharmacovigilance-history-eaeu/)

## Optional
- [Sitemap index](https://www.biomapas.com/sitemap_index.xml)